Statin use Associated With Decreased Mortality Risk in Patients With COVID-19
Researchers conducted a meta-analysis to assess the effects of statin use on mortality outcomes in patients with SARS-CoV-2 infection.
All articles by Sweta Gupta
Associations Found Between Plasma SARS-CoV-2 Viral RNA and COVID-19 Severity, Mortality
Researchers conducted a study to determine whether SARS-CoV-2 viral RNA detected in the bloodstreams of patients with COVID-19 is reflective of viremia or related to host immune responses and outcomes.
Effects of Umifenovir in Patients Hospitalized with Moderate to Severe COVID-19
In a randomized clinical trial, researchers assessed the effectiveness of umifenovir in combination with other drugs for the treatment of patients hospitalized with moderate to severe COVID-19.
Glucocorticoids Treatment Response: COVID-19 vs Severe Acute Respiratory Syndrome
In this meta-analysis of studies on COVID-19 and SARS, researchers compared the association between all-cause mortality and treatment with glucocorticoids.
Prophylactic Enoxaparin in Severe COVID-19: Standard vs Intermediate Dose
Researchers conducted a multi-center, open-label, randomized controlled trial to compare the effects of enoxaparin at the standard prophylactic dose with the intermediate dose for the treatment of adult patients with severe COVID-19.
Respiratory Virus Detections, Antibiotic Prescribing Rates Decreased During COVID-19 Pandemic
The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.
Sex Differences in Mortality After Tuberculosis Treatment
Researchers studied patients with pulmonary tuberculosis to better understand the impact of sex on mortality and sputum microbiological status after treatment initiation.
Pneumococcal Vaccine Associated With Steep Decline in Antibiotic Use Among Young Children in Israel
Researchers compared trends in antibiotic prescription rates during the period preceding the pneumococcal conjugate vaccine (PCV), as well as the early and late PCV periods, among Jewish vs Bedouin children.
Study Finds 4-Month Tuberculosis Treatment Noninferior to Standard of Care
Researchers conducted a phase 3 trial to ascertain whether treatment regimens including rifapentine with or without moxifloxacin can provide a lasting cure for drug-susceptible pulmonary tuberculosis in 4 months vs 6 months of standard therapy.
Pfizer-Biotech COVID-19 Vaccine Antibody Response Lower in Older Adults
Researchers compared the antibody responses of 2 age groups, one younger than 60 years and one older than 80 years, to the first and second doses of the Pfizer-BioNTech COVID-19 vaccination.
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...